{"schema_version":"1","generated_at":"2026-10-30T02:21:32.582Z","data_as_of":null,"url":"https://www.findmykol.com/kol/cindy-leissinger","json_url":"https://www.findmykol.com/kol/cindy-leissinger/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"cindy-leissinger","name":"Cindy Leissinger","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Tulane University","institution_url":"https://www.findmykol.com/institution/tulane-university","city":"New Orleans","state":"LA","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1700839933","openalex":"A5080646091"},"summary":"Cindy Leissinger is an Oncology physician affiliated with Tulane University. OpenAlex indexes 185 publications with 6,704 citations (h-index 35); ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":185,"cited_by_count":6704,"h_index":35,"latest_activity_year":2025,"source":"works"},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT01178333","title":"Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study","status":"COMPLETED","role":"Overall official","sponsor":"Carelon Research","source_url":"https://clinicaltrials.gov/study/NCT01178333","trial_url":"https://www.findmykol.com/trial/NCT01178333"},{"nct":"NCT00991939","title":"Initial Treatment of Patients With Immune Thrombocytopenic Purpura","phase":"PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"Carelon Research","source_url":"https://clinicaltrials.gov/study/NCT00991939","trial_url":"https://www.findmykol.com/trial/NCT00991939"},{"nct":"NCT00799773","title":"Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP)","phase":"PHASE3","status":"TERMINATED","role":"Overall official","sponsor":"Carelon Research","source_url":"https://clinicaltrials.gov/study/NCT00799773","trial_url":"https://www.findmykol.com/trial/NCT00799773"}],"source":"trials"},"payments":{"company_count":17,"program_years":{"first":2021,"last":null},"rows_total":30,"shown":3,"withheld":27,"rows":[{"payer":"CSL Behring","program_year":2025,"amount_usd":572.87,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700839933"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":38.97,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700839933"},{"payer":"Takeda Pharmaceuticals U.S.A., Inc.","program_year":2025,"amount_usd":27,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1700839933"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1700839933","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Blood & clotting","share_pct":68.9,"classes_total":4,"classes":[{"class":"Vitamin K antagonist","setting":"prescribed","share_pct":31.8,"drugs":[{"name":"Warfarin Sodium","share_pct":100}],"max_beneficiaries":null},{"class":"Low Molecular Weight Heparin","setting":"prescribed","share_pct":15.9,"drugs":[{"name":"Enoxaparin Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":23.8,"classes_total":2,"classes":[{"class":"Antimetabolite","setting":"prescribed","share_pct":14.6,"drugs":[{"name":"Hydroxyurea","share_pct":100}],"max_beneficiaries":null},{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":9.3,"drugs":[{"name":"Celecoxib","share_pct":100}],"max_beneficiaries":null}]},{"area":"Other","share_pct":7.3,"classes_total":1,"classes":[{"class":"Iron Chelator","setting":"prescribed","share_pct":7.3,"drugs":[{"name":"Deferasirox","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":4,"fiscal_years":{"first":1991,"last":2012},"rows_total":18,"shown":3,"withheld":15,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"U01HL072274","title":"Hemostasis Clinical Research Network Protocols","fiscal_year":2012,"amount_usd":"15782","organization":"TULANE UNIVERSITY OF LOUISIANA","source_url":"https://reporter.nih.gov/quickSearch/U01HL072274"},{"project":"U01HL072274","title":"Hemostasis Clinical Research Network Protocols","fiscal_year":2009,"amount_usd":"186250","organization":"TULANE UNIVERSITY OF LOUISIANA","source_url":"https://reporter.nih.gov/quickSearch/U01HL072274"},{"project":"U01HL072274","title":"Hemostasis Clinical Research Network Protocols","fiscal_year":2007,"amount_usd":"186250","organization":"TULANE UNIVERSITY OF LOUISIANA","source_url":"https://reporter.nih.gov/quickSearch/U01HL072274"}],"source":"grants"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program","year":2022,"journal":"Journal of Thrombosis and Haemostasis","source_url":"https://doi.org/10.1111/jth.15713","status":"verified"},{"title":"B cell–activating factor modulates the factor VIII immune response in hemophilia A","year":2021,"journal":"Journal of Clinical Investigation","source_url":"https://doi.org/10.1172/jci142906","status":"verified"},{"title":"Laboratory variability in the diagnosis of type 2 VWD variants","year":2020,"journal":"Journal of Thrombosis and Haemostasis","source_url":"https://doi.org/10.1111/jth.15129","status":"verified"},{"title":"Acquired hemophilia <scp>A</scp>: Updated review of evidence and treatment guidance","year":2017,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.24777","status":"verified"},{"title":"Clinical outcomes in a cohort of patients with heparin‐induced thrombocytopenia","year":2017,"journal":"American Journal of Hematology","source_url":"https://doi.org/10.1002/ajh.24759","status":"verified"}],"source":"works"},"contact":{"address_1":"1415 TULANE AVE","address_2":"HC-62","city":"New Orleans","state":"LA","zip":"701122600","phone":"504-988-6300","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1700839933","source":"identity"},"similar":[{"name":"Roy Weiner","slug":"roy-weiner","institution":"Tulane University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/roy-weiner","json_url":"https://www.findmykol.com/kol/roy-weiner/profile.json"},{"name":"Vadym Rusnak","slug":"vadym-rusnak","institution":"Tulane University","specialty":"Nephrology","url":"https://www.findmykol.com/kol/vadym-rusnak","json_url":"https://www.findmykol.com/kol/vadym-rusnak/profile.json"},{"name":"Alan Kaye","slug":"alan-kaye","institution":"Tulane University","specialty":"Pain Medicine","url":"https://www.findmykol.com/kol/alan-kaye","json_url":"https://www.findmykol.com/kol/alan-kaye/profile.json"},{"name":"Erik Castle","slug":"erik-castle","institution":"Tulane University","specialty":"Urology","url":"https://www.findmykol.com/kol/erik-castle","json_url":"https://www.findmykol.com/kol/erik-castle/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":27,"funding":15,"publications":45}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2017-04-19","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}